Narcolepsy is a neurological disorder that affects the sleep-wake cycle, resulting in excessive daytime sleepiness, sleep paralysis, and cataplexy. It is often misdiagnosed or overlooked, leading to a delay in diagnosis and treatment. This article aims to provide an overview of the disorder, its symptoms, diagnosis, and management.
Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness (EDS) and other symptoms including cataplexy, sleep paralysis, and hypnagogic hallucinations. It affects around 1 in 2,000 people, although the exact prevalence is unknown. Narcolepsy is caused by a disruption in the brain’s ability to regulate sleep and wakefulness. It is thought to be caused by a combination of genetic and environmental factors.
The most common symptom of narcolepsy is EDS, which is an overwhelming feeling of fatigue and sleepiness that cannot be alleviated by rest. Other symptoms include:
The diagnosis of narcolepsy is based on clinical history, physical examination, and laboratory tests. The most common laboratory tests used to diagnose narcolepsy include the multiple sleep latency test (MSLT) and the polysomnogram (PSG). The MSLT is a daytime test that measures how quickly a person falls asleep and how long they stay asleep. The PSG is an overnight test that records brain activity, breathing, and other body functions during sleep.
The goal of treatment is to improve the symptoms of narcolepsy and improve the quality of life. Treatment may include medications, lifestyle changes, and psychotherapy. Medications used to treat narcolepsy include stimulants, antidepressants, and sodium oxybate. Stimulants help to reduce daytime sleepiness and improve alertness. Antidepressants can help reduce cataplexy and hypnagogic hallucinations. Sodium oxybate is used to treat cataplexy and can improve nighttime sleep. Lifestyle changes such as regular exercise, a healthy diet, and avoiding caffeine and alcohol can also help to improve symptoms. Psychotherapy can help with stress management and coping with the emotional impact of the disorder.
Narcolepsy is a neurological disorder that affects the sleep-wake cycle, resulting in excessive daytime sleepiness, sleep paralysis, and cataplexy. It is often misdiagnosed or overlooked, leading to a delay in diagnosis and treatment. Treatment of narcolepsy includes medications, lifestyle changes, and psychotherapy. It is important to seek medical advice if you think you may have narcolepsy, as early diagnosis and treatment can help to reduce the impact of the disorder.
1.
Remote monitoring can improve recovery from cancer surgery
2.
Intractable cancers may respond better to treatment when using new radiation and high-performance computing.
3.
A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials
4.
Conditional EU Nod for Weekly Pill in Pediatric Glioma
5.
high response rate when using a bispecific antibody to treat R/R multiple myeloma.
1.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
2.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
5.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation